Management of postinfarct ventricular tachycardias.
The clinical profile of patients with postinfarct VT has changed in the past two decades. Along with these changes, existing treatments have improved, and entirely new therapeutic approaches have been developed. The expanded range of treatment options has made postinfarct VT a less imposing clinical problem than it once was. Emerging therapies promise to make an even greater beneficial impact. The challenge in treating patients with postinfarct VT has changed from merely keeping patients alive to keeping up with innovations in therapy that can provide them with a better quantity and quality of life.
Miller
J M
JM
Indiana University School of Medicine, Krannert Institute of Cardiology, Indianapolis, USA. jmiller6@iupui.edu
Coppess
M A
MA
Altemose
G T
GT
Gervacio-Domingo
G
G
Scott
L R
LR
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D017115:Catheter Ablation; D004562:Electrocardiography; D006339:Heart Rate; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications* / Q000503:physiopathology; D017180:Tachycardia, Ventricular / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D016896:Treatment Outcome
D000889:Anti-Arrhythmia Agents